Skip to Main Content

Paper Details

CD34+ selection and the severity of oropharyngeal mucositis in total body irradiation-based allogeneic stem cell transplantation.
Support Care Cancer
4
2016
CD34+, GVHD, OM, PATIENTS, PBSCs, T, TBI, graft versus host disease, human, human leukocyte antigen, methotrexate, oropharyngeal mucositis, patients, peripheral blood stem cells, stem cell
Author NameAffiliation
Christopher S Houriganand Blood Institute, National Institutes of Health
Sawa Itoand Blood Institute, National Institutes of Health
Sawa Itoand Blood Institute, National Institutes of Health
David F StroncekClinical Center, National Institutes of Health
David F StroncekClinical Center, National Institutes of Health
  • 1 - 5

Datasets

Release 1.2